GRI Bio begins patent enrollment for Phase 2a study of GRI-0621 for IPF treatment – Yahoo Finance
GRI Bio begins patent enrollment for Phase 2a study of GRI-0621 for IPF treatment Yahoo Finance
In: PATENT NEWS
GRI Bio begins patent enrollment for Phase 2a study of GRI-0621 for IPF treatment Yahoo Finance
In: PATENT NEWS
The Inflation Reduction Act of 2022 and its implications on the pharmaceutical industry. Minimum continuing legal education (MCLE) credit is pending …
In: PATENT NEWS
Cosponsors of S.3486 – 112th Congress (2011-2012): Patent Law Treaties Implementation Act of 2012.
In: PATENT NEWS
Edwards Loses Battle To Defend Heart-Valve Patent At EPO Law360
In: PATENT NEWS
It’s Not Always Obvious: A Successful Showing of Substantial Evidence Before the Federal Circuit JD Supra
In: PATENT NEWS
Patent Filings Roundup: Slow Week at PTAB and District Court; VLSI Saga Continues IPWatchdog.com
In: PATENT NEWS
Brushed Aside? Dafni Tries to Keep its PTAB Win against Ontel Patently-O
In: PATENT NEWS
Daiichi Sankyo scores $182M from Novartis settlement in long-running patent case FiercePharma
In: PATENT NEWS
A new job in the patent world: IP finance and insurance strategic advisors IAM
In: PATENT NEWS
Takeaways from PTAB’s Precedential Decision on Prior Art Analysis for Post-AIA Patents IPWatchdog.com
Designed by Industrial Action
Copyright © 2024 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION